These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1768626)

  • 1. Epidemiology of acute promyelocytic leukemia in Italy. APL Collaborating Group.
    Avvisati G; Mele A; Stazi MA; Vegna ML; Pasquini P; Mandelli F
    Ann Oncol; 1991 Jun; 2(6):405-8. PubMed ID: 1768626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP).
    Biondi A; Rovelli A; Cantù-Rajnoldi A; Fenu S; Basso G; Luciano A; Rondelli R; Mandelli F; Masera G; Testi AM
    Leukemia; 1994 Aug; 8(8):1264-8. PubMed ID: 8057659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP).
    Biondi A; Rovelli A; Cantù-Rajnoldi A; Fenu S; Basso G; Luciano A; Rondelli R; Mandelli F; Masera G; Testi AM
    Leukemia; 1994; 8 Suppl 2():S66-70. PubMed ID: 7815842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood acute promyelocytic leukemia in Nicaragua.
    Malta Corea A; Pacheco Espinoza C; Cantù Rajnoldi A; Conter V; Lietti G; Masera G; Sessa C; Cavalli F; Biondi A; Rovelli A
    Ann Oncol; 1993 Dec; 4(10):892-4. PubMed ID: 8117610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of acute promyelocytic leukemia.
    Mele A; Stazi MA; Pulsoni A; Visani G; Monarca B; Castelli G; Rocchi L; Avvisati G; Mandelli F
    Haematologica; 1995; 80(5):405-8. PubMed ID: 8566879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia. GIMEMA Cooperative Group.
    Pulsoni A; Stazi A; Cotichini R; Allione B; Cerri R; Di Bona E; Nosari AM; Pagano L; Recchia A; Ribersani M; Rocchi L; Veneri D; Visani G; Mandelli F; Mele A
    Eur J Haematol; 1998 Nov; 61(5):327-32. PubMed ID: 9855248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysis.
    Chen Z; Mai W; Li Z; Zhang H; Zheng Y; Hong S; Yang W; Xiao W; Chen Z; Wang S
    Leuk Lymphoma; 2019 Dec; 60(14):3470-3481. PubMed ID: 31305195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
    Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
    Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis.
    Li S; Chen L; Jin W; Ma X; Ma Y; Dong F; Zhu H; Li J; Wang K
    Sci Rep; 2017 Dec; 7(1):17998. PubMed ID: 29269861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An epidemiological investigation of adult acute leukemia in Fujian Province in 2010].
    Clinical Collaborative Group, Hematological Branch of Fujian Medical Association
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):902-5. PubMed ID: 23363744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
    Braun T; Cereja S; Chevret S; Raffoux E; Beaumont M; Detourmignies L; Pigneux A; Thomas X; Bordessoule D; Guerci A; Lamy T; Recher C; Poiré X; Tournilhac O; Spertini O; Chomienne C; Degos L; Dombret H; Adès L; Fenaux P;
    Cancer; 2015 Jul; 121(14):2393-9. PubMed ID: 25845577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study.
    Paulson K; Serebrin A; Lambert P; Bergeron J; Everett J; Kew A; Jones D; Mahmud S; Meloche C; Sabloff M; Sharif I; Storring J; Turner D; Seftel MD
    Br J Haematol; 2014 Sep; 166(5):660-6. PubMed ID: 24780059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early death in acute promyelocytic leukemia: Evidence from a rural cancer center.
    Golamari KR; Mikkilineni A; Chappidi S
    Indian J Cancer; 2020; 57(4):451-456. PubMed ID: 33078753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
    Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
    Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
    Lobe I; Rigal-Huguet F; Vekhoff A; Desablens B; Bordessoule D; Mounier C; Ferrant A; Sanz M; Fey M; Chomienne C; Chevret S; Degos L; Fenaux P;
    Leukemia; 2003 Aug; 17(8):1600-4. PubMed ID: 12886249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of acute promyelocytic leukaemia.
    Douer D
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):357-67. PubMed ID: 12935956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia.
    Jillella AP; Kota VK
    Blood Rev; 2018 Mar; 32(2):89-95. PubMed ID: 29033137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?
    Murray CK; Estey E; Paietta E; Howard RS; Edenfield WJ; Pierce S; Mann KP; Bolan C; Byrd JC
    J Clin Oncol; 1999 Jan; 17(1):293-7. PubMed ID: 10458245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide-based therapy is suitable for patients with psoriasis-associated acute promyelocytic leukemia - A retrospective clinical study.
    Ge F; Zhang Y; Cao F; Li J; Hou J; Wang P; Li H; Xu M; Liu S; Li L; Li X; Wang S; Lv C; Su Y; Zhou J
    Hematology; 2016 Jun; 21(5):287-94. PubMed ID: 26871996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.